{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:12:57Z","timestamp":1773094377967,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Res Involv Engagem"],"DOI":"10.1186\/s40900-024-00631-w","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:03:44Z","timestamp":1730891024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Embedding patient engagement in the R&D process of a life sciences company through co-creation with a patient expert R&D board: a case study"],"prefix":"10.1186","volume":"10","author":[{"given":"Estelle","family":"Jobson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6385-3372","authenticated-orcid":false,"given":"Marta","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4610-5804","authenticated-orcid":false,"given":"Danika","family":"Sharek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9470-4364","authenticated-orcid":false,"given":"Laura","family":"Risue\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Arnould","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Lemoine-Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9058-5097","authenticated-orcid":false,"given":"Jan","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-1166","authenticated-orcid":false,"given":"Ana","family":"Amariutei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6653-6463","authenticated-orcid":false,"given":"Sabrina","family":"Grigolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4494-3663","authenticated-orcid":false,"given":"Begonya","family":"Nafria Escalera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriana","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"key":"631_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.pec.2008.08.017","volume":"74","author":"K Taylor","year":"2009","unstructured":"Taylor K. Paternalism, participation and partnership\u2014the evolution of patient centeredness in the consultation. Patient Educ Couns. 2009;74:150\u20135.","journal-title":"Patient Educ Couns"},{"key":"631_CR2","unstructured":"World Health Organization. Constitution of the World Health Organization [Internet]. WHO; 1948 [cited 2024 Feb 1]. Available from: https:\/\/www.who.int\/about\/accountability\/governance\/constitution"},{"key":"631_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s43441-019-00034-0","volume":"54","author":"S Stergiopoulos","year":"2020","unstructured":"Stergiopoulos S, Michaels DL, Kunz BL, Getz KA. Measuring the impact of patient engagement and patient centricity in clinical research and development. Ther Innov Regul Sci. 2020;54:103\u201316. https:\/\/doi.org\/10.1007\/s43441-019-00034-0.","journal-title":"Ther Innov Regul Sci"},{"key":"631_CR4","unstructured":"U.S. FDA PEAC. Patient Engagement in Medical Device Clinical Trials: Discussion Document [Internet]. U.S. FDA; 2018 [cited 2024 Feb 15]. Available from: https:\/\/www.fda.gov\/media\/117890\/download"},{"key":"631_CR5","unstructured":"U.S. FDA. Patient Engagement in the Design and Conduct of Medical Device Clinical Studies: Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders [Internet]. Patient Engagem. Des. Conduct Med. Device Clin. Stud. FDA; 2022 [cited 2024 Feb 15]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-engagement-design-and-conduct-medical-device-clinical-studies"},{"key":"631_CR6","unstructured":"U.S. Food and Drug Administration. FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient\u2019s Voice in Medical Product Development and Regulatory Decision Making (Four Guidances) [Internet]. FDA. 2024 [cited 2024 Feb 1]. Available from: https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical"},{"key":"631_CR7","unstructured":"U.S. FDA. Patient-Focused Drug Development: Collecting Comprehensive and Representative Input [Internet]. FDA; 2018 Jun. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-focused-drug-development-collecting-comprehensive-and-representative-input"},{"key":"631_CR8","unstructured":"U.S. Food and Drug Administration. Benefit-Risk Assessment for New Drug and Biological Products: Guidance for Industry [Internet]. U.S. FDA; 2023 Oct. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/benefit-risk-assessment-new-drug-and-biological-products"},{"key":"631_CR9","unstructured":"CIOMS Working Group XI on Patient involvement in the development, regulation and safe use of medicines. Patient involvement in the development, regulation and safe use of medicines [Internet]. Council for International Organizations of Medical Sciences (CIOMS); 2022. Available from: https:\/\/cioms.ch\/publications\/product\/patient-involvement\/"},{"key":"631_CR10","unstructured":"European Medicines Agency. Principles on the involvement of young patients\/consumers within EMA activities [Internet]. 2017 May. Report No.: EMA\/494077\/2016. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/principles-involvement-young-patientsconsumers-within-ema-activities_en.pdf"},{"key":"631_CR11","unstructured":"European Medicines Agency. Engagement Framework: EMA and patients, consumers and their organisations [Internet]. EMA; 2022 [cited 2024 Feb 1]. Available from: https:\/\/www.ema.europa.eu\/system\/files\/documents\/other\/updated_engagement_framework_-_ema_and_patients_consumers_and_their_organisations_2022-en.pdf"},{"key":"631_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s43441-023-00573-7","volume":"58","author":"N Bertelsen","year":"2024","unstructured":"Bertelsen N, Dewulf L, Ferr\u00e8 S, Vermeulen R, Schroeder K, Gatellier L, et al. Patient engagement and patient experience data in regulatory review and health technology assessment: a global landscape review. Ther Innov Regul Sci. 2024;58:63\u201378. https:\/\/doi.org\/10.1007\/s43441-023-00573-7.","journal-title":"Ther Innov Regul Sci"},{"key":"631_CR13","doi-asserted-by":"publisher","DOI":"10.1377\/hpb20130214.898775\/full\/healthpolicybrief_86.pdf","author":"J James","year":"2013","unstructured":"James J. Health policy brief: patient engagement. Health Aff. 2013. https:\/\/doi.org\/10.1377\/hpb20130214.898775\/full\/healthpolicybrief_86.pdf.","journal-title":"Health Aff"},{"key":"631_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40271-017-0216-1","volume":"10","author":"D Wong-Rieger","year":"2017","unstructured":"Wong-Rieger D. Moving from patient advocacy to partnership: a long and bumpy road. Patient Patient-Centered Outcomes Res. 2017;10:271\u20136. https:\/\/doi.org\/10.1007\/s40271-017-0216-1.","journal-title":"Patient Patient-Centered Outcomes Res"},{"key":"631_CR15","doi-asserted-by":"crossref","unstructured":"Marie-Pascale Pomey and Paule Lebel. Patient Engagement: The Quebec Path*. Healthc Pap [Internet]. 2016;16:80\u20135. Available from: https:\/\/www.longwoods.com\/content\/24998\/patient-engagement-the-quebec-path-","DOI":"10.12927\/hcpap.2017.24998"},{"key":"631_CR16","doi-asserted-by":"publisher","DOI":"10.17061\/phrp3222211","author":"C Vargas","year":"2022","unstructured":"Vargas C, Whelan J, Brimblecombe J, Allender S. Co-creation, co-design, co-production for public health \u2013 a perspective on definition and distinctions. Public Health Res Pract. 2022. https:\/\/doi.org\/10.17061\/phrp3222211.","journal-title":"Public Health Res Pract"},{"key":"631_CR17","unstructured":"Scilife. Life Sciences Industry: Complete Definition and Examples [Internet]. Life Sci. Ind. Complete Defin. Ex. 2023 [cited 2024 Feb 1]. Available from: https:\/\/www.scilife.io\/glossary\/life-science"},{"key":"631_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/bmjinnov-2016-000157","volume":"3","author":"G Yeoman","year":"2017","unstructured":"Yeoman G, Furlong P, Seres M, Binder H, Chung H, Garzya V, et al. Defining patient centricity with patients for patients and caregivers: a collaborative endeavour. BMJ Innov. 2017;3:76\u201383. https:\/\/doi.org\/10.1136\/bmjinnov-2016-000157.","journal-title":"BMJ Innov"},{"key":"631_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11136-017-1577-6","volume":"27","author":"H Wilson","year":"2018","unstructured":"Wilson H, Dashiell-Aje E, Anatchkova M, Coyne K, Hareendran A, Leidy NK, et al. Beyond study participants: a framework for engaging patients in the selection or development of clinical outcome assessments for evaluating the benefits of treatment in medical product development. Qual Life Res. 2018;27:5\u201316. https:\/\/doi.org\/10.1007\/s11136-017-1577-6.","journal-title":"Qual Life Res"},{"key":"631_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1021\/pr0499693","volume":"3","author":"AD Weston","year":"2004","unstructured":"Weston AD, Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res. 2004;3:179\u201396. https:\/\/doi.org\/10.1021\/pr0499693.","journal-title":"J Proteome Res"},{"key":"631_CR21","doi-asserted-by":"publisher","first-page":"e2022009","DOI":"10.2349\/mdl.v113i1.12622","volume":"113","author":"P Boffetta","year":"2022","unstructured":"Boffetta P, Collatuzzo G. Application of P4 (predictive, preventive, personalized, participatory) approach to occupational medicine. Med Lav Work Environ Health. 2022;113:e2022009. https:\/\/doi.org\/10.2349\/mdl.v113i1.12622.","journal-title":"Med Lav Work Environ Health"},{"key":"631_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40900-022-00334-0","volume":"8","author":"O Gorbenko","year":"2022","unstructured":"Gorbenko O, Cavillon P, Giles RH, Kolarova T, Marks M, Cardone A, et al. Co-creating with patients an impact framework across the medicine\u2019s life cycle: a qualitative study exploring patients\u2019 experiences of involvement in and perceptions of impact measures. Res Involv Engagem. 2022;8:1. https:\/\/doi.org\/10.1186\/s40900-022-00334-0.","journal-title":"Res Involv Engagem"},{"key":"631_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5694\/j.1326-5377.2003.tb05532.x","volume":"179","author":"AE Bauman","year":"2003","unstructured":"Bauman AE, Fardy HJ, Harris PG. Getting it right: why bother with patient-centred care? Med J Aust. 2003;179:253\u20136. https:\/\/doi.org\/10.5694\/j.1326-5377.2003.tb05532.x.","journal-title":"Med J Aust"},{"key":"631_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1472-6963-14-89","volume":"14","author":"JP Domecq","year":"2014","unstructured":"Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014;14:89. https:\/\/doi.org\/10.1186\/1472-6963-14-89.","journal-title":"BMC Health Serv Res"},{"key":"631_CR25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.healthpol.2018.02.007","volume":"122","author":"S Malfait","year":"2018","unstructured":"Malfait S, Van Hecke A, De Bodt G, Palsterman N, Eeckloo K. Patient and public involvement in hospital policy-making: Identifying key elements for effective participation. Health Policy. 2018;122:380\u20138.","journal-title":"Health Policy"},{"key":"631_CR26","unstructured":"Ryll B. 12\/52: The difference between patients and patient advocates [Internet]. 1252 Differ. Patients Patient Advocates. 2022 [cited 2024 Feb 11]. Available from: https:\/\/www.mpneurope.org\/post\/12-52-the-difference-between-patients-and-patient-advocates"},{"key":"631_CR27","unstructured":"National Institute for Health and Care Research (NIHR). A brief guide to public involvement in funding applications [Internet]. Brief Guide Public Involv. Funding Appl. 2020 [cited 2024 Feb 1]. Available from: https:\/\/www.nihr.ac.uk\/documents\/a-brief-guide-to-public-involvement-in-funding-applications\/24162"},{"key":"631_CR28","doi-asserted-by":"publisher","first-page":"103702","DOI":"10.1016\/j.drudis.2023.103702","volume":"28","author":"FI Auwal","year":"2023","unstructured":"Auwal FI, Copeland C, Clark EJ, Naraynassamy C, McClelland GR. A systematic review of models of patient engagement in the development and life cycle management of medicines. Drug Discov Today. 2023;28:103702.","journal-title":"Drug Discov Today"},{"key":"631_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/2168479017716715","volume":"52","author":"B Levitan","year":"2018","unstructured":"Levitan B, Getz K, Eisenstein EL, Goldberg M, Harker M, Hesterlee S, et al. Assessing the financial value of patient engagement: a quantitative approach from CTTI\u2019s patient groups and clinical trials project. Ther Innov Regul Sci. 2018;52:220\u20139. https:\/\/doi.org\/10.1177\/2168479017716715.","journal-title":"Ther Innov Regul Sci"},{"key":"631_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3389\/fmed.2018.00251\/full","volume":"5","author":"I Klingmann","year":"2018","unstructured":"Klingmann I, Heckenberg A, Warner K, Haerry D, Hunter A, May M, et al. EUPATI and patients in medicines research and development: guidance for patient involvement in ethical review of clinical trials. Front Med. 2018;5:251. https:\/\/doi.org\/10.3389\/fmed.2018.00251\/full.","journal-title":"Front Med"},{"key":"631_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40900-023-00477-8","volume":"9","author":"J Preston","year":"2023","unstructured":"Preston J, Biglino G, Harbottle V, Dalrymple E, Stalford H, Beresford MW. Reporting involvement activities with children and young people in paediatric research: a framework analysis. Res Involv Engagem. 2023;9:61. https:\/\/doi.org\/10.1186\/s40900-023-00477-8.","journal-title":"Res Involv Engagem"},{"key":"631_CR32","doi-asserted-by":"publisher","first-page":"e071339","DOI":"10.1136\/bmjopen-2022-071339","volume":"13","author":"S-A Dews","year":"2023","unstructured":"Dews S-A, Bassi A, Buckland S, Clements L, Daley R, Davies A, et al. Characterising meaningful patient and public involvement in the pharmaceutical industry research setting: a retrospective quality assessment. BMJ Open. 2023;13:e071339.","journal-title":"BMJ Open"},{"key":"631_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/hex.13191","volume":"24","author":"LE Vat","year":"2021","unstructured":"Vat LE, Finlay T, Robinson P, Barbareschi G, Boudes M, Diaz Ponce AM, et al. Evaluation of patient engagement in medicine development: a multi-stakeholder framework with metrics. Health Expect. 2021;24:491\u2013506. https:\/\/doi.org\/10.1111\/hex.13191.","journal-title":"Health Expect"},{"key":"631_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.17294\/2330-0698.1859","volume":"9","author":"S Fruytier","year":"2022","unstructured":"Fruytier S, Vat LE, Camp R, Hou\u00ffez F, Keyser HD, Dunne D, et al. Monitoring and evaluation of patient engagement in health product research and development: co-creating a framework for community advisory boards. J Patient-Centered Res Rev. 2022;9:46\u201357.","journal-title":"J Patient-Centered Res Rev"},{"key":"631_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40900-021-00255-4","volume":"7","author":"A L\u2019Esp\u00e9rance","year":"2021","unstructured":"L\u2019Esp\u00e9rance A, O\u2019Brien N, Gr\u00e9goire A, Abelson J, Canfield C, Del Grande C, et al. Developing a Canadian evaluation framework for patient and public engagement in research: study protocol. Res Involv Engagem. 2021;7:10.","journal-title":"Res Involv Engagem"},{"key":"631_CR36","unstructured":"Servier. Annual Report 2020\/2021 [Internet]. Available from: https:\/\/servier.com\/wp-content\/uploads\/2022\/09\/servier-annual-report-2020-21.pdf"},{"key":"631_CR37","doi-asserted-by":"publisher","first-page":"336ps11","DOI":"10.1126\/scitranslmed.aaf6730","volume":"8","author":"M Anderson","year":"2016","unstructured":"Anderson M, Kimberly MK. On the path to a science of patient input. Sci Transl Med. 2016;8:336ps11. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6730.","journal-title":"Sci Transl Med"},{"key":"631_CR38","unstructured":"Clinical Trials Transformation Initiative (CTTI). Presenting CTTI Recommendations: Effective Engagement with Patient Groups Around Clinical Trials [Internet]. CTTI. 2015 [cited 2024 Feb 1]. Available from: https:\/\/ctti-clinicaltrials.org\/presenting-ctti-recommendations-effective-engagement-with-patient-groups-around-clinical-trials\/"},{"key":"631_CR39","unstructured":"Patvocates. About Patvocates: Who we are [Internet]. 2023 [cited 2024 Feb 1]. Available from: https:\/\/www.patvocates.net\/about-patvocates\/"},{"key":"631_CR40","unstructured":"Innovative Medicines Initiative (IMI). IMI Innovative Medicines Initiative [Internet]. Eur. Patients Acad. Ther. Innov. Summ. 2017 [cited 2024 Feb 1]. Available from: http:\/\/www.imi.europa.eu\/projects-results\/project-factsheets\/eupati"},{"key":"631_CR41","unstructured":"EUPATI. Email correspondence: Number of qualified EUPATI Fellows. 2023."},{"key":"631_CR42","unstructured":"European Patients\u2019 Academy on Therapeutic Innovation. EUPATI Annual Report 2023. 2024 [cited 2024 Feb 15]; Available from: https:\/\/eupati.eu\/wp-content\/uploads\/2024\/02\/EUPATI-Annual-Report-2023-7.pdf"},{"key":"631_CR43","unstructured":"Patient Focused Medicines Development. Patient Engagement Quality Guidance v 2.0 [Internet]. PFMD; 2018 [cited 2024 Feb 1]. Available from: https:\/\/patientfocusedmedicine.org\/peqg\/patient-engagement-quality-guidance.pdf"},{"key":"631_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjinnov-2018-000317","author":"K Deane","year":"2019","unstructured":"Deane K, Delbecque L, Gorbenko O, Hamoir AM, Hoos A, Nafria B, et al. Co-creation of patient engagement quality guidance for medicines development: an international multistakeholder initiative. BMJ Innov. 2019. https:\/\/doi.org\/10.1136\/bmjinnov-2018-000317.","journal-title":"BMJ Innov"},{"key":"631_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40900-022-00341-1","volume":"8","author":"DP Richards","year":"2022","unstructured":"Richards DP, Cobey KD, Proulx L, Dawson S, de Wit M, Toupin-April K. Identifying potential barriers and solutions to patient partner compensation (payment) in research. Res Involv Engagem. 2022;8:7.","journal-title":"Res Involv Engagem"},{"key":"631_CR46","unstructured":"Servier, BioLabs Global. Press release: Servier and BioLabs call for applications to join Spartners, the integrated incubator within the future Servier Research and Development Institute in Paris-Saclay [Internet]. Servier and BioLabs Global, media departments; 2022 [cited 2024 Feb 1]. Available from: https:\/\/servier.com\/wp-content\/uploads\/2022\/10\/servier-biolabs-application-spartners_PR.pdf"},{"key":"631_CR47","unstructured":"Servier. Servier Integrated Annual Report 2021\/2022 [Internet]. Available from: https:\/\/servier.com\/wp-content\/uploads\/2023\/03\/servier-integrated-annual-report-2021-22.pdf"}],"container-title":["Research Involvement and Engagement"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40900-024-00631-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40900-024-00631-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40900-024-00631-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:09:26Z","timestamp":1730891366000},"score":1,"resource":{"primary":{"URL":"https:\/\/researchinvolvement.biomedcentral.com\/articles\/10.1186\/s40900-024-00631-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["631"],"URL":"https:\/\/doi.org\/10.1186\/s40900-024-00631-w","relation":{},"ISSN":["2056-7529"],"issn-type":[{"value":"2056-7529","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This manuscript reports author experiences of a retrospective case study; no data collection was conducted as part of this case study. As such, ethical approval and consent to participate were not required. All authors of this study were members of the patient board described in the research or employees of the life sciences company, and no external participants were involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable. All authors consent to be named accordingly. All people thanked in the Acknowledgements section consent to being acknowledged, too.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Some authors (SA, AL, LR, and GM) are full-time employees of Servier. No authors own Servier stocks. One author (JG) is CEO of the patient consultancy, Patvocates. One author (DS) is a part-time employee of Patvocates. One author (AA) is both a full-time employee of Patvocates and a member of the patient board. The co-corresponding author (EJ), and patient contributors (AA, SG, BN, TS, OS, LS, JW) are members of the Servier Saclay R&D Patient Expert Board, as described in the article, and their affiliation appears accordingly.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}